Accurate cancer staging is critical not only for planning the clinical management, but also for predicting prognosis in patients with pancreatic ductal adenocar
Background: Patients with advanced hepatobiliary cancer (HBC) have a dismal prognosis and limited treatment options. Immunotherapy has been considered as a prom
Primary liver cancer, of which hepatocellular carcinoma (HCC) represents the vast majority of cases, is the second highest cause of cancer-related death world-w